Analyses / Public Summary / 119 · HR 6009 Public Summary

119-HR-6009 Journalist Public Summary

119 · HR 6009 Defense Biotechnology Strategy Act

A House bill would require the Pentagon to deliver, within one year, a comprehensive strategy for how emerging biotechnologies affect national security, including supply chains, standards, and work with allies; it was introduced on November 10, 2025 and sent to the Armed Services and Foreign Affairs Committees. [1]Congress.gov (Library of Congress) — Text of H.R.6009 (Introduced in House) — D…[2]Congress.gov (Library of Congress) — H.R.6009 (119th): Defense Biotechnology St…

Published
11 Nov 2025
Updated
11 Nov 2025
Tags
Public Summary · U.S. Congress · 119th Congress
Unvetted
01 · Section

Document 119-HR-6009 • Public Summary

1) Headline Summary: The Defense Biotechnology Strategy Act tells the Pentagon to produce a one-year plan for using and governing new biotechnologies in defense—covering manufacturing, standards, procurement tools, exercises, and NATO coordination. [1]Congress.gov (Library of Congress) — Text of H.R.6009 (Introduced in House) — D…

2) What It Does: The bill directs the Secretary of Defense to submit a strategy to Congress within a year that lays out how DoD will build and tap commercial biomanufacturing capacity, update military specs to incorporate bio-based products, use advance market commitments/offtake agreements, factor biotech into wargames, explore a research “grand challenge” to make biotech more predictably engineerable, stand up a regulation science and technology program (with digital infrastructure and biometrology tools), and work with NATO partners on pooled purchasing and shared research. [1]Congress.gov (Library of Congress) — Text of H.R.6009 (Introduced in House) — D…

3) Who’s For It:

  • Lead sponsor: Rep. Chrissy Houlahan (D‑PA). [2]Congress.gov (Library of Congress) — H.R.6009 (119th): Defense Biotechnology St…
  • Original cosponsor: Rep. Pete Sessions (R‑TX). The introduced text lists him alongside the sponsor, indicating bipartisan backing at introduction. [1]Congress.gov (Library of Congress) — Text of H.R.6009 (Introduced in House) — D…
  • Public statements from supporters were not posted on Congress.gov as of November 11, 2025; the bill text emphasizes supply chain resilience, updated standards, and allied coordination as the focus. [1]Congress.gov (Library of Congress) — Text of H.R.6009 (Introduced in House) — D…

4) Who’s Against It:

  • No organized opposition is identified at introduction; debates will likely surface in committee. [2]Congress.gov (Library of Congress) — H.R.6009 (119th): Defense Biotechnology St…
  • Common concerns with similar proposals include cost, dual‑use risks (civilian tech with military misuse potential), and how new programs are overseen across agencies.

5) What’s Next: The bill was introduced on November 10, 2025 and referred to the House Armed Services Committee and the House Foreign Affairs Committee. Next steps typically include hearings and/or a committee markup before any House floor vote. [2]Congress.gov (Library of Congress) — H.R.6009 (119th): Defense Biotechnology St…

6) Tone: This summary aims to be neutral, factual, and easy to read.

Sources cited
  1. [1] Text of H.R.6009 (Introduced in House) — Defense Biotechnology Strategy Act Congress.gov (Library of Congress)
  2. [2] H.R.6009 (119th): Defense Biotechnology Strategy Act — Overview (sponsor, committees, latest action) Congress.gov (Library of Congress)

Discussion